Cristina Varas-Lorenzo

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level
    Cristina Varas-Lorenzo
    Global Epidemiology, Safety and Risk Management, Pfizer Worldwide Development, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 16:366-76. 2007
  2. ncbi Use of oral corticosteroids and the risk of acute myocardial infarction
    Cristina Varas-Lorenzo
    Pfizer Worldwide Development, Global Epidemiology, Sant Cugat del Vallès, Barcelona, Spain
    Atherosclerosis 192:376-83. 2007
  3. ncbi The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
    Cristina Varas-Lorenzo
    Pfizer, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 18:1016-25. 2009
  4. ncbi Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)
    Jordi Castellsague
    RTI Health Solutions, Barcelona, Spain
    Drug Saf 35:1127-46. 2012
  5. ncbi Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database
    Cristina Varas-Lorenzo
    RTI Health Solutions, Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 17:842-52. 2008
  6. ncbi Stroke risk and NSAIDs: a systematic review of observational studies
    Cristina Varas-Lorenzo
    RTI Health Solutions, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 20:1225-36. 2011
  7. ncbi Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population
    Cristina Varas-Lorenzo
    Novartis Farmaceutica S.A, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 15:317-26. 2006
  8. ncbi Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction
    Sonia Hernandez-Diaz
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Basic Clin Pharmacol Toxicol 98:266-74. 2006
  9. ncbi Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population
    Consuelo Huerta
    Centro Español de Investigación Farmacoepidemiológica, Spanish Centre for Pharmacoepidemiologic Research, Madrid, Spain
    Am J Kidney Dis 45:531-9. 2005
  10. ncbi Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population
    Luis A Garcia Rodriguez
    Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain
    Circulation 109:3000-6. 2004

Detail Information

Publications11

  1. ncbi Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level
    Cristina Varas-Lorenzo
    Global Epidemiology, Safety and Risk Management, Pfizer Worldwide Development, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 16:366-76. 2007
    ....
  2. ncbi Use of oral corticosteroids and the risk of acute myocardial infarction
    Cristina Varas-Lorenzo
    Pfizer Worldwide Development, Global Epidemiology, Sant Cugat del Vallès, Barcelona, Spain
    Atherosclerosis 192:376-83. 2007
    ..A few epidemiological studies suggested an increased coronary heart disease (CHD) risk with high doses of oral corticosteroids...
  3. ncbi The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
    Cristina Varas-Lorenzo
    Pfizer, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 18:1016-25. 2009
    ....
  4. ncbi Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)
    Jordi Castellsague
    RTI Health Solutions, Barcelona, Spain
    Drug Saf 35:1127-46. 2012
    ....
  5. ncbi Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database
    Cristina Varas-Lorenzo
    RTI Health Solutions, Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 17:842-52. 2008
    ..Case definitions are essential to epidemiological research...
  6. ncbi Stroke risk and NSAIDs: a systematic review of observational studies
    Cristina Varas-Lorenzo
    RTI Health Solutions, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 20:1225-36. 2011
    ..To perform a quantitative systematic review of observational studies on the risk of stroke associated with the use of individual NSAIDs...
  7. ncbi Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population
    Cristina Varas-Lorenzo
    Novartis Farmaceutica S.A, Global Epidemiology, Barcelona, Spain
    Pharmacoepidemiol Drug Saf 15:317-26. 2006
    ..CONCLUSION: A notable proportion of elderly people is affected by some degree of glucose metabolism impairment which in turn is associated with cardiovascular co-morbidity...
  8. ncbi Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction
    Sonia Hernandez-Diaz
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Basic Clin Pharmacol Toxicol 98:266-74. 2006
    ..There was a suggestion of a small increased risk with ibuprofen. Also, data suggest a small reduced risk for naproxen present only in non-users of aspirin, mainly people free of clinically apparent vascular disease...
  9. ncbi Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population
    Consuelo Huerta
    Centro Español de Investigación Farmacoepidemiológica, Spanish Centre for Pharmacoepidemiologic Research, Madrid, Spain
    Am J Kidney Dis 45:531-9. 2005
    ..Despite these studies, little is known about the effect of dose and duration of therapy, risk of individual NSAIDs, comorbidity, or concomitant use of other nephrotoxic drugs...
  10. ncbi Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population
    Luis A Garcia Rodriguez
    Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain
    Circulation 109:3000-6. 2004
    ..Some reports suggest that concurrent aspirin and ibuprofen might be associated with lower cardioprotection than aspirin alone because of a pharmacodynamic interaction...
  11. ncbi Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data
    Christianne L Roumie
    Veterans Administration, Tennessee Valley Healthcare System, Tennessee Valley Geriatric Research Education Clinical Center GRECC, Nashville, TN 37212, USA
    Pharmacoepidemiol Drug Saf 17:20-6. 2008
    ..To validate ICD 9 codes with a high positive predictive value (PPV) for incident strokes. The study population consisted of Tennessee Medicaid enrollees aged from 50 to 84 years...